MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517034426 A) filed by Urteste S. A., Gdansk, Poland, on April 8, for 'compound diagnostic marker for ovarian cancer method for detecting enzymatic activity method for diagnosis of ovarian cancer kit comprising the compound uses of the compound and method for the treatment of ovarian cancer.'
Inventor(s) include Lesner Adam; and Gruba Natalia.
The application for the patent was published on June 13, under issue no. 24/2025.
According to the abstract released by the Intellectual Property India: "The invention relates to a novel chemical compound a diagnostic marker for use in medicine more specifically in cancer diagnosis in particular the diagnosis of ovarian cancer. The invention also relates to an in vitro method for detecting enzymatic activity present in a subjects body fluid in particular derived from ovarian cancer cells using the compound. The invention further relates to an in vitro method for diagnosing ovarian cancer using the compound a kit comprising the compound and use of the compound for the detection of enzymatic activity specific to ovarian cancer and use of the compound for the diagnosis of ovarian cancer. The invention also relates to the compound for use as a diagnostic marker of ovarian cancer and a method for the treatment of ovarian cancer comprising a step of carrying out the method for the diagnosis of ovarian cancer as defined above using the compound."
The patent application was internationally filed on Sept. 27, 2023, under International application No.PCT/PL2023/050081.
Disclaimer: Curated by HT Syndication.
